Oxidative stress induces macroautophagy of amyloid β-protein and ensuing apoptosis

Free Radical Biology and Medicine

Volumn 46, Issue 3, 2009, Pages 422-429

  Zheng, Lin ^a   Kågedal, Katarina ^a   Dehvari, Nodi ^b   Benedikz, Eirikur ^b   Cowburn, Richard ^c   Marcusson, Jan ^a   Terman, Alexei ^a,d  

^a LINKÖPING UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alzheimer disease; Amyloid protein; Amyloid precursor protein; Apoptosis; Autophagy; Free radicals; Lysosomes; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL LINE; CELL PERMEABILIZATION; LYSOSOME MEMBRANE; OXIDATIVE STRESS; PRIORITY JOURNAL; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOPTOSIS; AUTOPHAGY; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; HUMANS; INTRACELLULAR MEMBRANES; LYSOSOMES; MUTANT PROTEINS; NEURONS; OXIDATIVE STRESS; OXYGEN; TRANSFECTION; TRANSGENES;

EID: 58149173970     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.10.043     Document Type: Article

References (51)

1. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 430 (2004) 631-639
2. Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci. 17 (2001) 137-145
3. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
4. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
5. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
6. Oddo S., Caccamo A., Tran L., Lambert M.P., Glabe C.G., Klein W.L., and LaFerla F.M. Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease: a link between Abeta and tau pathology. J. Biol. Chem. 281 (2006) 1599-1604
7. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., and Ashe K.H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440 (2006) 352-357
8. Estus S., Golde T.E., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X.M., Tabira T., Greenberg B.D., et al. Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. Science 255 (1992) 726-728
9. Golde T.E., Estus S., Younkin L.H., Selkoe D.J., and Younkin S.G. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science 255 (1992) 728-730
10. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., Lieberburg I., Koo E.H., Schenk D., Teplow D.B., et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
11. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., et al. Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359 (1992) 325-327
12. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., Cai X.D., McKay D.M., Tintner R., Frangione B., et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258 (1992) 126-129
13. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001) 741-766
14. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., and Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360 (1992) 672-674
15. Cai X.D., Golde T.E., and Younkin S.G. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. Science 259 (1993) 514-516
16. D'Andrea M.R., Nagele R.G., Gumula N.A., Reiser P.A., Polkovitch D.A., Hertzog B.M., and Andrade-Gordon P. Lipofuscin and Abeta42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains. Neurosci. Lett. 323 (2002) 45-49
17. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., and Relkin N.R. Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156 (2000) 15-20
18. Takahashi R.H., Milner T.A., Li F., Nam E.E., Edgar M.A., Yamaguchi H., Beal M.F., Xu H., Greengard P., and Gouras G.K. Intraneuronal Alzheimer Abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161 (2002) 1869-1879
19. Zhu X., Su B., Wang X., Smith M.A., and Perry G. Causes of oxidative stress in Alzheimer disease. Cell. Mol. Life Sci. 64 (2007) 2202-2210
20. Huang X., Moir R.D., Tanzi R.E., Bush A.I., and Rogers J.T. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann. N. Y. Acad. Sci. 1012 (2004) 153-163
21. Ding Q., Dimayuga E., and Keller J.N. Oxidative damage, protein synthesis, and protein degradation in Alzheimer's disease. Curr. Alzheimer Res. 4 (2007) 73-79
22. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., et al. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65 (1995) 2146-2156
23. Boyd-Kimball D., Sultana R., Mohmmad-Abdul H., and Butterfield D.A. Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): implications for proposed mechanisms of toxicity. J. Alzheimers Dis. 6 (2004) 515-525
24. Yatin S.M., Varadarajan S., and Butterfield D.A. Vitamin E prevents Alzheimer's amyloid beta-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. J. Alzheimers Dis. 2 (2000) 123-131
25. Adamec E., Mohan P.S., Cataldo A.M., Vonsattel J.P., and Nixon R.A. Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease. Neuroscience 100 (2000) 663-675
26. Yu W.H., Cuervo A.M., Kumar A., Peterhoff C.M., Schmidt S.D., Lee J.H., Mohan P.S., Mercken M., Farmery M.R., Tjernberg L.O., Jiang Y., Duff K., Uchiyama Y., Naslund J., Mathews P.M., Cataldo A.M., and Nixon R.A. Macroautophagy-a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 171 (2005) 87-98
27. Langui D., Girardot N., El Hachimi K.H., Allinquant B., Blanchard V., Pradier L., and Duyckaerts C. Subcellular topography of neuronal Abeta peptide in APPxPS1 transgenic mice. Am. J. Pathol. 165 (2004) 1465-1477
28. Ditaranto K., Tekirian T.L., and Yang A.J. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol. Dis. 8 (2001) 19-31
29. Yang A.J., Chandswangbhuvana D., Margol L., and Glabe C.G. Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1-42 pathogenesis. J. Neurosci. Res. 52 (1998) 691-698
30. Terman A., Neuzil J., Kagedal K., Ollinger K., and Brunk U.T. Decreased apoptotic response of inclusion-cell disease fibroblasts: a consequence of lysosomal enzyme missorting?. Exp. Cell Res. 274 (2002) 9-15
31. Ariga T., Jarvis W.D., and Yu R.K. Role of sphingolipid-mediated cell death in neurodegenerative diseases. J. Lipid Res. 39 (1998) 1-16
32. Deiss L.P., Galinka H., Barissi H., Cohen O., and Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-a. EMBO J. 15 (1996) 3861-3870
33. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M., and Jäättelä M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153 (2001) 999-1010
34. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., Kaufmann S.H., and Gores G.J. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106 (2000) 1127-1137
35. Kågedal K., Johansson U., and Öllinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J. 15 (2001) 1592-1594
36. Roberg K., Kågedal K., and Öllinger K. Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts. Am. J. Pathol. 161 (2002) 89-96
37. Roberg K., and Öllinger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am. J. Pathol. 152 (1998) 1151-1156
38. Brunk U.T., Dalen H., Roberg K., and Hellquist H.B. Photo-oxidative disruption of lysosomal membranes causes apoptosis of cultured human fibroblasts. Free Radic. Biol. Med. 23 (1997) 616-626
39. Zheng L., Roberg K., Jerhammar F., Marcusson J., and Terman A. Autophagy of amyloid beta-protein in differentiated neuroblastoma cells exposed to oxidative stress. Neurosci. Lett. 394 (2006) 184-189
40. Harman D. Aging and disease: extending functional life span. Ann. N. Y. Acad. Sci. 786 (1996) 321-336
41. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11 (1956) 298-300
42. Sohal R.S., and Weindruch R. Oxidative stress, caloric restriction, and aging. Science 273 (1996) 59-63
43. Lin H., Bhatia R., and Lal R. Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15 (2001) 2433-2444
44. Quist A., Doudevski I., Lin H., Azimova R., Ng D., Frangione B., Kagan B., Ghiso J., and Lal R. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. USA 102 (2005) 10427-10432
45. Ji Z.S., Mullendorff K., Cheng I.H., Miranda R.D., Huang Y., and Mahley R.W. Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration. J. Biol. Chem. 281 (2006) 2683-2692
46. Cataldo A.M., Barnett J.L., Berman S.A., Li J., Quarless S., Bursztajn S., Lippa C., and Nixon R.A. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14 (1995) 671-680
47. Cataldo A.M., Barnett J.L., Pieroni C., and Nixon R.A. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J. Neurosci. 17 (1997) 6142-6151
48. Boya P., Gonzalez-Polo R.A., Casares N., Perfettini J.L., Dessen P., Larochette N., Metivier D., Meley D., Souquere S., Yoshimori T., Pierron G., Codogno P., and Kroemer G. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25 (2005) 1025-1040
49. Su Y., and Chang P.T. Acidic pH promotes the formation of toxic fibrils from beta-amyloid peptide. Brain Res. 893 (2001) 287-291
50. Tamagno E., Parola M., Bardini P., Piccini A., Borghi R., Guglielmotto M., Santoro G., Davit A., Danni O., Smith M.A., Perry G., and Tabaton M. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92 (2005) 628-636
51. Misonou H., Morishima-Kawashima M., and Ihara Y. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 39 (2000) 6951-6959